Northwest Cancer Specialists-Vancouver Cancer Center — Vancouver, Washington

Northwest Cancer Specialists-Vancouver Cancer Center is a clinical research site located in Vancouver, Washington, United States 98684.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Northwest Cancer Specialists-Vancouver Cancer Center has participated in 7 clinical trials.

Therapeutic areas: B-Cell Lymphoma, B-Cell Leukemia, Neoplasms.

Sponsors: Pharmacyclics LLC., Adherex Technologies, Inc., Merrimack Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Vancouver

Browse all research sites in Washington · View every site in Vancouver

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northwest Cancer Specialists-Vancouver Cancer Center?

Northwest Cancer Specialists-Vancouver Cancer Center has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northwest Cancer Specialists-Vancouver Cancer Center conducted?

Northwest Cancer Specialists-Vancouver Cancer Center has 7 clinical trials on record. Their work covers B-Cell Lymphoma, B-Cell Leukemia, Neoplasms.

Is Northwest Cancer Specialists-Vancouver Cancer Center accredited by Crixeo Clinical Trials?

Northwest Cancer Specialists-Vancouver Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northwest Cancer Specialists-Vancouver Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.